PDA gives company conceptual approval
By Jeff McMenemy

PORTSMOUTH — Lonza Biologics has received conceptual approval from the Pease Development Authority to move forward with its “cell therapy expansion project.”

PDA Board of Director member Peter Loughlin said the cell therapy involves advancements made on the treatment of macular degeneration.

“I don’t know if they create it or just manufacture it,” Loughlin said Monday.

Macular degeneration is the “leading cause of vision loss, affecting more than 10 million Americans – more than cataracts and glaucoma combined,” according to the American Macular Degeneration Foundation’s website.

The project includes fitting out about 60,000 square feet of a building the company constructed at its 101 International Drive site at the Pease International Tradeport in 2007, according to a memo from Maria Stowell, the PDA’s engineering manager, and comments made at a recent Portsmouth Planning Board and Portsmouth Board of Adjustment meeting.

The project, according to Stowell’s memo, also includes building a mezzanine with cooling towers, adding a “nitrogen tank” on site, constructing a series of electric improvements, including “four transformers, one control house, two generators with fuel tanks and a duct bank system.”

Planning Board Vice Chairman Elizabeth Moreau asked about security around the tanks during Thursday’s Planning Board meeting.

“You don’t want anyone wandering in there,” Moreau said.

Patrick Crimmins, a senior engineer at Tighe and Bond in Portsmouth, said during the recent Planning Board meeting that two new proposed diesel tanks will be located outside and “fenced in with 8-foot high guardrail fence,” and the area will also be gated off too.

The Planning Board recommended that the PDA grant final approval and the Board of Adjustment also voted to grant a variance needed because the above ground storage tanks for the diesel fuel hold more than 2,000 gallons.

Crimmins told BOA members that Lonza needs the diesel fuel to make sure they never lose power.

“With the high tech medical manufacturing that they do, they need specific controls,” in terms of “temperature and sterilization,” Crimmins said.

“They really can’t lose power,” Crimmins said……….

Read more: http://www.seacoastonline.com/article/20150622/NEWS/150629717/101017/NEWS

Source: Seacoast Online